Maria Grazia Vitale

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 264 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone et al. · European Journal of Cancer · 2020 · 117 citations

Life Sciences, Immunology, Oncology +17

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

Vincenzo Montesarchio, Roberto Parella, Chiara Iommelli et al. · Journal for ImmunoTherapy of Cancer · 2020 · 90 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

Paolo A. Ascierto, Milena Casula, Jenny Bulgarelli et al. · Nature Communications · 2024 · 89 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Alessio Cortellini, Antonio D’Alessio, Siobhan Cleary et al. · Clinical Cancer Research · 2023 · 74 citations · Full text

Medicine, Immunology, Oncology +16